1. Home
  2. Companies
  3. Coherus BioSciences
  4. Financial Ratios
  5. DSO Ratio
Coherus BioSciences logo
Coherus BioSciences CHRS
$ 1.68 1.82%

Annual report 2025
added 03-09-2026

report update icon

Coherus BioSciences DSO Ratio 2011-2026 | CHRS

Annual DSO Ratio Coherus BioSciences

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
559 2.57 K 263 201 157 115 146 - - 3.57 19 49.7 36.9 - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
2.57 K 3.57 375

Quarterly DSO Ratio Coherus BioSciences

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
56.6 292 1.03 K - 2.58 K 1.89 K 10.1 K - 219 189 297 - 91.6 88.8 182 - 154 147 163 - 126 106 117 105 116 155 175 - - - - - - 0.85 534 201 1.04 12.1 12.6 14 19.9 20.7 31.2 34 13.7 44.4 34.2 10.3 - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
10.1 K 0.85 524

DSO Ratio of other stocks in the Biotechnology industry

Issuer DSO Ratio Price % 24h Market Cap Country
Adverum Biotechnologies Adverum Biotechnologies
ADVM
 		222 - - $ 86.2 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
 		48.3 - -24.86 % $ 820 K usaUSA
I-Mab I-Mab
IMAB
 		271 - - $ 866 M chinaChina
Akebia Therapeutics Akebia Therapeutics
AKBA
 		62.9 $ 1.4 -0.71 % $ 360 M usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		84.7 - - $ 40.3 B usaUSA
Aravive Aravive
ARAV
 		16.8 - -13.39 % $ 1.45 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		2.75 K - -1.52 % $ 24.7 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
 		28.1 $ 2.92 -0.34 % $ 6.35 B israelIsrael
Aytu BioScience Aytu BioScience
AYTU
 		150 $ 2.55 -0.78 % $ 16 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		204 - -18.52 % $ 27.3 M britainBritain
Advaxis Advaxis
ADXS
 		88.1 - -9.65 % $ 45.9 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
 		70.9 $ 20.37 -2.4 % $ 952 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
 		103 $ 4.08 -2.16 % $ 436 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		61.7 - - $ 7.46 M israelIsrael
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
 		106 $ 24.21 -1.47 % $ 3.08 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
 		52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
Aeterna Zentaris Aeterna Zentaris
AEZS
 		146 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
 		186 - -10.17 % $ 12.2 K usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
 		321 $ 32.24 -4.1 % $ 2.14 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		216 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		0.114 - - $ 26.5 M usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
 		182 - - $ 3.45 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		17.9 - 1.93 % $ 17.4 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
 		45.6 - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
 		2.26 K - - $ 1.41 B usaUSA
Immutep Limited Immutep Limited
IMMP
 		351 $ 0.31 -2.52 % $ 1.08 B australiaAustralia
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
 		6.83 - - $ 169 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
 		13.6 - - $ 867 M germanyGermany
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
 		147 - - $ 401 M usaUSA
Celsion Corporation Celsion Corporation
CLSN
 		15.6 - -6.63 % $ 13.9 M usaUSA